JBM (Healthcare) Limited

Equities

2161

KYG1090B1077

Pharmaceuticals

Delayed Hong Kong S.E. 04:08:15 2024-04-18 am EDT 5-day change 1st Jan Change
0.92 HKD 0.00% Intraday chart for JBM (Healthcare) Limited +2.22% -12.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
JBM Group Group Limited Announces Revision of the Existing Annual Caps for the Continuing Connected Transactions Under the 2023 Manufacturing Services Agreement CI
JBM Limited Announces Board Changes, Effective 9 March 2024 CI
JBM Limited Announces Change of Company Secretary CI
JBM (Healthcare) Hikes Dividend as Six-Month Profit Soars 189% MT
JBM Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023 CI
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
JBM (Healthcare) Forecasts Threefold Jump in Fiscal H1 Profit MT
JBM Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2023 CI
JBM Limited commences an Equity Buyback Plan for 91,368,600 shares, representing 10% of its issued share capital, under the authorization approved on August 1, 2023. CI
JBM Limited Approves Final Cash Dividend for the Year Ended March 31, 2023 CI
JBM (Healthcare)'s FY23 Attributable Profit More Than Doubles MT
JBM Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
JBM Limited Proposes Final Dividend for the Financial Year End 31 March 2023, Payable on 01 September 2023 CI
JBM (Healthcare) Expects 130% Rise in FY23 Attributable Profit MT
JBM Limited Provides Earnings Guidance for the Year Ended 31 March 2023 CI
JBM Limited completed the acquisition of remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 19 million. CI
JBM Healthcare to Take Full Ownership of Chinese Medicines JV MT
JBM Group Limited agreed to acquire the remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 17 million. CI
JBM Healthcare's Profit for Six Months Through September Doubles MT
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
JBM Limited Declares Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022 CI
JBM (Healthcare) Expects Up to 120% Increase in April-September Profit; Shares Rally 12% MT
JBM Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months Ended 30 September 2022 CI
JBM Limited Announces Change of Headquarters and Principal Place of Business in Hong Kong CI
JBM Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Chart JBM (Healthcare) Limited
More charts
JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2161 Stock
  4. News JBM (Healthcare) Limited
  5. JBM (Healthcare) : Signs JV Deal With Tycoon Group for Marketing, Distribution of Supplements, Health Products